NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 32 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,694,590 | +17.7% | 3,125,000 | 0.0% | 0.16% | +13.3% |
| Q2 2023 | $3,989,479 | -5.8% | 3,125,000 | 0.0% | 0.14% | -4.0% |
| Q1 2023 | $4,235,941 | -14.6% | 3,125,000 | 0.0% | 0.15% | -34.6% |
| Q4 2022 | $4,960,077 | +39.8% | 3,125,000 | +25.0% | 0.23% | +41.6% |
| Q3 2022 | $3,547,000 | +113.7% | 2,500,000 | +100.0% | 0.16% | +177.6% |
| Q2 2022 | $1,660,000 | – | 1,250,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |